266 related articles for article (PubMed ID: 15050315)
1. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy.
Fang FM; Tsai WL; Chiu HC; Kuo WR; Hsiung CY
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1394-404. PubMed ID: 15050315
[TBL] [Abstract][Full Text] [Related]
2. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
Allal AS; Nicoucar K; Mach N; Dulguerov P
Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
[TBL] [Abstract][Full Text] [Related]
5. Impact of dysphagia on quality of life after treatment of head-and-neck cancer.
Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett A; Barloon J; Sallah S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):772-8. PubMed ID: 15708256
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma.
Fang FM; Tsai WL; Chien CY; Chen HC; Hsu HC; Huang TL; Lee TF; Huang HY; Lee CH
J Clin Oncol; 2010 Oct; 28(28):4384-9. PubMed ID: 20713853
[TBL] [Abstract][Full Text] [Related]
7. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
8. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma.
van Meerten E; van der Gaast A; Looman CW; Tilanus HW; Muller K; Essink-Bot ML
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):160-6. PubMed ID: 18164846
[TBL] [Abstract][Full Text] [Related]
9. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
10. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
[TBL] [Abstract][Full Text] [Related]
11. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
13. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
14. [A prospective longitudinal study examining the impact on short term quality of life of hand video-assisted thoracoscopic surgical esophagectomy in patients with esophageal cancer].
Guan QM; Du JJ; Meng L; Chen JH
Zhonghua Wai Ke Za Zhi; 2007 May; 45(10):688-91. PubMed ID: 17688822
[TBL] [Abstract][Full Text] [Related]
15. [Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting].
Fu JH; Rong TH; Li XD; Ma GW; Hu Y; Min HQ
Ai Zheng; 2003 Jan; 22(1):91-4. PubMed ID: 12561445
[TBL] [Abstract][Full Text] [Related]
16. Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia.
Blazeby JM; Metcalfe C; Nicklin J; Barham CP; Donovan J; Alderson D
Br J Surg; 2005 Dec; 92(12):1502-7. PubMed ID: 16252311
[TBL] [Abstract][Full Text] [Related]
17. [Quality of life of 192 disease-freely survival nasopharyngeal carcinoma patients after radiotherapy].
Wu Y; Hu WH; Xia YF; Ma J; Liu MZ; Cui NJ
Ai Zheng; 2005 Nov; 24(11):1376-83. PubMed ID: 16552967
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma.
Qiao XY; Wang W; Zhou ZG; Gao XS; Chang JY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):396-402. PubMed ID: 17855004
[TBL] [Abstract][Full Text] [Related]
19. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
[TBL] [Abstract][Full Text] [Related]
20. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A;
J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
